Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 45 clinical trials
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency. Vitamin D replacement may improve tumor response and survival and delay time to treatment in patients with cancer who are vitamin D insufficient.

b-cell lymphoma
calcium
cluster of differentiation
peripheral t-cell lymphoma
large cell lymphoma
  • 87 views
  • 27 Jan, 2021
  • 2 locations
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK ROS1 OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor kinase genes encoding TRK kinase family (NTRK1-3) alterations …

tyrosine
measurable disease
ROS1
lymphoma
cancer
  • 0 views
  • 03 Feb, 2021
  • 25 locations
Vinorelbine for Recurrent ALCL-2017

The purpose of this study is to assess the efficiency and safety of vinorelbine in the treatment of relapsed / advanced ALCL in children and adolescents.

stem cell transplantation
  • 6 views
  • 24 Jan, 2021
  • 1 location
A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)

The objective of this study is to evaluate efficacy and safety of TQ-B3101 in subjects with relapsed/refractory anaplastic large cell lymphoma (ALCL) .

  • 0 views
  • 23 Jan, 2021
  • 1 location
Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL

with relapsed and refractory ALK-positive Anaplastic Large Cell Lymphoma.

  • 1 views
  • 22 Jan, 2021
  • 1 location
  • 5 views
  • 23 Jan, 2021
  • 1 location
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

This phase II trial studies the side effects and how well brentuximab vedotin and combination chemotherapy work in treating patients with CD30-positive peripheral T-cell lymphoma. Brentuximab vedotin is a monoclonal antibody, brentuximab, linked to a toxic agent called vedotin. Brentuximab attaches to CD30 positive cancer cells in a targeted way …

measurable disease
peripheral t-cell lymphoma
large cell lymphoma
monoclonal antibodies
cancer
  • 7 views
  • 18 Feb, 2021
  • 8 locations
Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

The prognosis of PTCL (except early stage ALK+ ALCL) is dismal. Previous study showed that single agent lenalidomide showed promising therapeutic activity in patients with relapsed or refractory

  • 0 views
  • 24 Jan, 2021
  • 1 location
CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

CAR-T cells have been validated effective in treating CD19 positive B cell lymphoma. Other lymphomas like Hodgkin's lymphoma and anaplastic large cell lymphoma are CD30 positive. In this study

b-cell lymphoma
cancer
lymphoma
hodgkin's disease
  • 7 views
  • 21 Jan, 2021
  • 1 location
Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma

The purpose of this study is to test the safety and efficacy of AUTO4 a CAR T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive selected T-Non-Hodgkin Lymphoma.

measurable disease
lymphoma
cyclophosphamide
peripheral t-cell lymphoma
large cell lymphoma
  • 35 views
  • 26 Jan, 2021
  • 5 locations